• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MorphoSys AG - American Depositary Shares (NQ:MOR)

18.96 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 18.96
Bid (Size) 17.81 (3)
Ask (Size) 19.00 (10)
Prev. Close 18.96
Today's Range 18.96 - 18.96
52wk Range 18.39 - 19.00
Shares Outstanding 32,890,046
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Morpheus Launches $20 Million In Rewards For AI Compute Providers
December 11, 2024
Morpheus, a decentralized platform for deploying AI-driven “Smart Agents,” has launched a $20 million reward program for compute providers. 
Via Benzinga
Topics Artificial Intelligence
Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual General Meeting
August 27, 2024
Via ACCESSWIRE

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+1.9%
+1.9%

More News

Read More
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, MOR, AFBI on Behalf of Shareholders
July 17, 2024
From Halper Sadeh LLC
Via GlobeNewswire
3 Global Stocks to Buy to Escape the Volatility on Wall Street
July 16, 2024
Via InvestorPlace
MorphoSys: Q4 Earnings Insights
March 13, 2024
Via Benzinga
Earnings Outlook For MorphoSys
March 12, 2024
Via Benzinga
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
July 12, 2024
From MorphoSys AG
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DM, SHCR, MOR, ALE on Behalf of Shareholders
July 08, 2024
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALLG, MOR, BEST, MGOL on Behalf of Shareholders
June 29, 2024
From Halper Sadeh LLC
Via GlobeNewswire
MOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of MorphoSys AG Is Fair to Shareholders
June 20, 2024
From Halper Sadeh LLC
Via Business Wire
MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders
June 20, 2024
From MorphoSys AG
Via Business Wire
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
June 19, 2024
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
May 27, 2024
Via Benzinga
MOR Stock Earnings: MorphoSys Misses EPS, Misses Revenue for Q1 2024
April 30, 2024
Via InvestorPlace
MorphoSys AG Reports First Quarter 2024 Financial Results
April 29, 2024
From MorphoSys AG
Via Business Wire
MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer Drug, Pelabresib
April 29, 2024
Via Benzinga
MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
April 24, 2024
Via ACCESSWIRE
Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends
April 23, 2024
Via Benzinga
MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
April 11, 2024
From MorphoSys AG
Via Business Wire
MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
April 11, 2024
Via ACCESSWIRE
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
March 21, 2024
Via ACCESSWIRE
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 13, 2024
From MorphoSys AG
Via Business Wire
Earnings Scheduled For March 13, 2024
March 13, 2024
Via Benzinga
5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024
March 09, 2024
Via Talk Markets
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
March 07, 2024
Via InvestorPlace

Frequently Asked Questions

Is MorphoSys AG - American Depositary Shares publicly traded?
Yes, MorphoSys AG - American Depositary Shares is publicly traded.
What exchange does MorphoSys AG - American Depositary Shares trade on?
MorphoSys AG - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for MorphoSys AG - American Depositary Shares?
The ticker symbol for MorphoSys AG - American Depositary Shares is MOR on the Nasdaq Stock Market
What is the current price of MorphoSys AG - American Depositary Shares?
The current price of MorphoSys AG - American Depositary Shares is 18.96
When was MorphoSys AG - American Depositary Shares last traded?
The last trade of MorphoSys AG - American Depositary Shares was at 08/02/24 04:00 PM ET
What is the market capitalization of MorphoSys AG - American Depositary Shares?
The market capitalization of MorphoSys AG - American Depositary Shares is 623.60M
How many shares of MorphoSys AG - American Depositary Shares are outstanding?
MorphoSys AG - American Depositary Shares has 624M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap